Crush The Market

undefined Logo

Idera Pharmaceuticals, Inc.

0.30 USD

-5.03%

Add To Watchlist

Symbol

IDRA

Market Cap

18.950 Million USD

Sector

Healthcare

Description

Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating solid tumors, squamous cell carcinoma of the head and neck, and colorectal cancer. The company has a collaboration agreement with Bristol-Meyers Squibb. Idera Pharmaceuticals, Inc. was incorporated in 1989 and is headquartered in Exton, Pennsylvania.

Website

https://www.iderapharma.com

Crush The Market

We Use Cookies